Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: APP Mutations
APPSw-NSE

General Information

Transgene: CMVAPP695sw construct, containing APPsw695, (gift of Tae-Wan Kim). The pNSE-CAT (gift from Dr. J. Gregor Sutcliffe). NSE-APPsw with the prokaryotic sequence eliminated, microinjected into BDF1.

Promoter: Rat NSE

Origin: C57BL/6 x DBA/2

Phenotype

Neuropathological analysis:

12-month-old tg mouse brains showed increased immunostaining for Aß-42 without plaque formations in cortex or hippocampus. In MAPK family, both JNK and p38 were activated, whereas there was no significant activation of the ERK. Tau phosphorylation was also enhanced in the tg relative to the control mice. Cox-2 levels, (WB and immunostaining) and significant caspase-3- and TUNEL-stained nuclei were detected in tg mice compared to the age-matched controls.

Behavioral:

In the water maze tests, 12-month-old transgenic mice had longer escape latencies, across the former platform location, than the age-matched control mice. These transgenic mice also showed increased escape distances in finding the former platform location.

Availability

Yong K. Kim
Division of Laboratory Animal Resources
Korea FDA, National Institute of Toxicological Research
5 Nokbun-dong Eunpyng-ku
Seoul 122-704, Korea
Telephone: +82-2-380-1835
Fax: +82-2-380-1833
Email: kimyongkyu@hanmail.net

Patents: APPsw-Transgenic Mice; Jung S. Cho / Yong K. Kim et al.; Filed 11/4/02

Reference

Primary:

Hwang DY, Cho JS, Lee SH, Chae KR, Lim HJ, Min SH, Seo SJ, Song YS, Song CW, Paik SG, Sheen YY, Kim YK. Aberrant expressions of pathogenic phenotype in Alzheimer's diseased transgenic mice carrying NSE-controlled APPsw. Exp Neurol. 2004 Mar ; 186(1):20-32. Abstract.

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad